618
Views
12
CrossRef citations to date
0
Altmetric
Original Articles: Research

Does cell-of-origin or MYC, BCL2 or BCL6 translocation status provide prognostic information beyond the International Prognostic Index score in patients with diffuse large B-cell lymphoma treated with rituximab and chemotherapy? A systematic review

, , &
Pages 2403-2418 | Received 09 Dec 2016, Accepted 23 Jan 2017, Published online: 09 Feb 2017
Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (2.5 MB)

Table S1: Immunohistochemistry studies using the Hans algorithm comparing GCB to non-GCB: Overall and progression-free survival.

Download MS Word (98.8 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.